Liver resection for hepatocellular carcinoma in patients with end-stage renal failure
β Scribed by Shao-Bin Cheng; Cheng-Chung Wu; Kuo-Hsiung Shu; William-Lin Ho; Jung-Ta Chen; Dah-Cherng Yeh; Tse-Jia Liu; Fang-Ku P'eng
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 100 KB
- Volume
- 78
- Category
- Article
- ISSN
- 0022-4790
- DOI
- 10.1002/jso.1160
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background and Objectives Because renal transplantation recipients require immunosuppressive drugs, they have a higher incidence of subsequent malignancies. Among them, hepatocellular carcinoma (HCC) is common. Although liver resection remains an option for curing HCC, the role of l
## Abstract ## Background Radioβfrequencyβassisted liver resection has been shown to allow virtually bloodless procedures without the need for vascular exclusion manoeuvres. Our primary endβpoint was to evaluate safety and feasibility of RFβassisted liver resection in cirrhotic patients with hepat
The best prioritization of patients with hepatocellular carcinoma (HCC) waiting for liver transplantation under the model for end-stage liver disease (MELD) allocation system is still being debated. We analyzed the impact of a MELD adjustment for HCC, which consisted of the addition of an extra scor